These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30946085)

  • 101. Is adjuvant chemotherapy necessary for patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery in locally advanced rectal cancer? Long-term analysis of 40 ypCR patients at a single center.
    Zhou J; Qiu H; Lin G; Xiao Y; Wu B; Wu W; Sun X; Lu J; Zhang G; Xu L; Liu Y
    Int J Colorectal Dis; 2016 Jun; 31(6):1163-8. PubMed ID: 27044403
    [TBL] [Abstract][Full Text] [Related]  

  • 102. The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation.
    Carpinetti P; Donnard E; Bettoni F; Asprino P; Koyama F; Rozanski A; Sabbaga J; Habr-Gama A; Parmigiani RB; Galante PA; Perez RO; Camargo AA
    Oncotarget; 2015 Nov; 6(35):38360-71. PubMed ID: 26451609
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer: The CARTS Study.
    Stijns RCH; de Graaf EJR; Punt CJA; Nagtegaal ID; Nuyttens JJME; van Meerten E; Tanis PJ; de Hingh IHJT; van der Schelling GP; Acherman Y; Leijtens JWA; Bremers AJA; Beets GL; Hoff C; Verhoef C; Marijnen CAM; de Wilt JHW;
    JAMA Surg; 2019 Jan; 154(1):47-54. PubMed ID: 30304338
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival.
    Kim NK; Baik SH; Seong JS; Kim H; Roh JK; Lee KY; Sohn SK; Cho CH
    Ann Surg; 2006 Dec; 244(6):1024-30. PubMed ID: 17122629
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Transanal Endoscopic Microsurgery (TEM) Following Neoadjuvant Chemoradiation for Rectal Cancer: Outcomes of Salvage Resection for Local Recurrence.
    Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Fernandez LM; de Azevedo RU; Vailati BB; Fernandes FA; Gama-Rodrigues J
    Ann Surg Oncol; 2016 Apr; 23(4):1143-8. PubMed ID: 26577119
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Watch and wait after a clinical complete response in rectal cancer patients younger than 50 years.
    Bahadoer RR; Peeters KCMJ; Beets GL; Figueiredo NL; Bastiaannet E; Vahrmeijer A; Temmink SJD; Meershoek-Klein Kranenbarg WME; Roodvoets AGH; Habr-Gama A; Perez RO; van de Velde CJH; Hilling DE;
    Br J Surg; 2021 Dec; 109(1):114-120. PubMed ID: 34738104
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Avoiding Unnecessary Major Rectal Cancer Surgery by Implementing Structural Restaging and a Watch-and-Wait Strategy After Neoadjuvant Radiochemotherapy.
    Huisman JF; Schoenaker IJH; Brohet RM; Reerink O; van der Sluis H; Moll FCP; de Boer E; de Graaf JC; de Vos Tot Nederveen Cappel WH; Beets GL; van Westreenen HL
    Ann Surg Oncol; 2021 May; 28(5):2811-2818. PubMed ID: 33170456
    [TBL] [Abstract][Full Text] [Related]  

  • 108. [Long-term conditional disease-free survival for rectal cancer patients underwent neoadjuvant chemoradiotherapy].
    Shen SH; Wu YL; Li DD; Zhang QQ; Feng L; Fang H; Zhu YL; Zhang HZ
    Zhonghua Zhong Liu Za Zhi; 2021 Dec; 43(12):1304-1309. PubMed ID: 34915641
    [No Abstract]   [Full Text] [Related]  

  • 109. The evaluation of follow-up strategies of watch-and-wait patients with a complete response after neoadjuvant therapy in rectal cancer.
    Haak HE; Žmuc J; Lambregts DMJ; Beets-Tan RGH; Melenhorst J; Beets GL; Maas M;
    Colorectal Dis; 2021 Jul; 23(7):1785-1792. PubMed ID: 33725387
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Watch and Wait Strategy for Rectal Cancer: How Long Should We Wait for a Clinical Complete Response?
    Asoglu O; Goksoy B; Aliyev V; Mustafayev TZ; Atalar B; Bakir B; Guven K; Demir G; Goksel S
    Surg Technol Int; 2022 May; 40():130-139. PubMed ID: 35090178
    [TBL] [Abstract][Full Text] [Related]  

  • 111. The importance of measuring baseline tumour volume (or alternatively tumour length along with its rectal circumferential extent) in the watch-and-wait strategy in rectal cancer: a review.
    Hołdakowska A; Gerard JP; Bujko K
    Acta Oncol; 2022 Sep; 61(9):1084-1092. PubMed ID: 36107959
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Watch-and-Wait is an Option in Rectal Cancer Patients: From Controversy to Common Clinical Practice.
    Grotenhuis BA; Beets GL
    Clin Oncol (R Coll Radiol); 2023 Feb; 35(2):124-129. PubMed ID: 36481218
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Obesity as an independent predictive factor for pathologic complete response after neoadjuvant chemoradiation in rectal cancer.
    Lee SY; Kim CH; Kim YJ; Kwak HD; Ju JK; Kim HR
    Ann Surg Treat Res; 2019 Mar; 96(3):116-122. PubMed ID: 30838183
    [TBL] [Abstract][Full Text] [Related]  

  • 114. The “Watch and wait” approach following chemoradiotherapy for rectal cancer: a case series and review of literature.
    D'Amata G; Manzi F; Florio G; Musmeci L; Antonellis F; Demoro M; Palmieri I; Falchetto MO; Del Papa M
    Ann Ital Chir; 2021; 92(5):531-538. PubMed ID: 33764331
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Conditional risk of diverticulitis after non-operative management.
    Garfinkle R; Almalki T; Pelsser V; Bonaffini P; Reinhold C; Morin N; Vasilevsky CA; Liberman AS; Boutros M
    Br J Surg; 2020 Dec; 107(13):1838-1845. PubMed ID: 32876945
    [TBL] [Abstract][Full Text] [Related]  

  • 116. The watch-and-wait strategy
    Lee C; Park IJ; Lim SB; Yu CS; Kim JC
    Ann Surg Treat Res; 2022 Dec; 103(6):350-359. PubMed ID: 36601336
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Rectal Sparing Approaches after Neoadjuvant Treatment for Rectal Cancer: A Systematic Review and Meta-Analysis Comparing Local Excision and Watch and Wait.
    Bao QR; Ferrari S; Capelli G; Ruffolo C; Scarpa M; Agnes A; Chiloiro G; Palazzari E; Urso EDL; Pucciarelli S; Spolverato G
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672414
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Clinical response assessment after contact X-Ray brachytherapy and chemoradiotherapy for organ preservation in rectal cancer T2-T3 M0: The time/dose factor influence.
    Benezery K; Montagne L; Evesque L; Schiappa R; Hannoun-Levi JM; Francois E; Thamphya B; Gerard JP
    Clin Transl Radiat Oncol; 2020 Sep; 24():92-98. PubMed ID: 32695890
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Word of caution: Rectal cancer without response to neoadjuvant treatment - Do not wait for surgery.
    Duraes LC; Kalady MF; Liska D; Gorgun E; Kessler H; Otero-Pineiro A; Steele SR; Valente MA
    Am J Surg; 2023 Oct; 226(4):548-552. PubMed ID: 37032235
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD).
    Temmink SJD; Peeters KCMJ; Bahadoer RR; Kranenbarg EM; Roodvoets AGH; Melenhorst J; Burger JWA; Wolthuis A; Renehan AG; Figueiredo NL; Pares O; Martling A; Perez RO; Beets GL; van de Velde CJH; Nilsson PJ;
    Br J Surg; 2023 May; 110(6):676-684. PubMed ID: 36972213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.